Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation. 2008

Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
College of Pharmacy, SungKyunKwan University, Su-Won 440-746, Korea.

Multidrug resistance (MDR) is a major problem in cancer chemotherapy. It was previously reported that a red ginseng saponin, 20(S)-ginsenoside Rg3 could modulate MDR in vitro and extend the survival of mice implanted with ADR-resistant murine leukemia P388 cells. This study examined the cytotoxicity of Rg3 on normal and transformed cells, along with its effect on the membrane fluidity. The cytotoxicity study revealed that 120 microM of Rg3 was cytotoxic against a multidrug-resistant human fibroblast carcinoma cell line, KB V20C, but not against normal WI 38 cells in vitro. Flow cytometric analysis using rhodamine 123 as the artificial substrate showed that Rg3 promoted the accumulation of rhodamine 123 in ADR-resistant murine leukemia P388 cells in vivo. Fluorescence polarization studies using the hydrophilic fluorescent probe, DPH, and hydrophobic probe, TMA-DPH, showed that 20 microM Rg3 induced a significant increase in fluorescence anisotropy in KB V20C cells but not in the parental KB cells. These results clearly show that Rg3 decreases the membrane fluidity thereby blocking drug efflux.

UI MeSH Term Description Entries
D007624 KB Cells This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences. HeLa-KB Cells,Cell, HeLa-KB,Cell, KB,Cells, HeLa-KB,Cells, KB,HeLa KB Cells,HeLa-KB Cell,KB Cell
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D008560 Membrane Fluidity The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature. Bilayer Fluidity,Bilayer Fluidities,Fluidities, Bilayer,Fluidities, Membrane,Fluidity, Bilayer,Fluidity, Membrane,Membrane Fluidities
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005454 Fluorescence Polarization Measurement of the polarization of fluorescent light from solutions or microscopic specimens. It is used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. Anisotropy, Fluorescence,Fluorescence Anisotropy,Polarization, Fluorescence,Anisotropies, Fluorescence,Fluorescence Anisotropies,Fluorescence Polarizations,Polarizations, Fluorescence
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
April 2014, Oncology letters,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
October 1987, Journal of the National Cancer Institute,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
January 1997, Yao xue xue bao = Acta pharmaceutica Sinica,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
May 2012, Molecular medicine reports,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
June 2003, Cancer research,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
March 2017, Journal of microbiology and biotechnology,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
January 1994, Journal of cancer research and clinical oncology,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
March 1993, British journal of cancer,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
April 2019, Translational cancer research,
Hyog-Young Kwon, and Eun-Hye Kim, and Seung-Whan Kim, and Su-Nam Kim, and Jong-Dae Park, and Dong-Kwon Rhee
June 2019, Oncology reports,
Copied contents to your clipboard!